Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds
BNT162b2 vaccine had favorable safety profile in 5- to 11-year-olds similar to that seen in other age groups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.